13F

CATX PERSPECTIVE THERAPEUTICS INC

2026Q1 · CUSIP 46489V302 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
135
Δ holders QoQ
+21
Breadth percentile
Top 15%
Whale holders
70
Δ whales
+11
Inst. holding value
$326M
New positions
47
Closed positions
26
Price momentum (1Q)
-22.5%
Put / Call
3/3

Breadth history (34 quarters)

2024Q3: Δ+24 · h=127 2024Q4: Δ+8 · h=135 2025Q1: Δ-24 · h=111 2025Q2: Δ-14 · h=97 2025Q3: Δ+7 · h=104 2025Q4: Δ+10 · h=114 2026Q1: Δ+21 · h=135 2024Q3: holders=127 2024Q4: holders=135 2025Q1: holders=111 2025Q2: holders=97 2025Q3: holders=104 2025Q4: holders=114 2026Q1: holders=135 -24 -12 +0 +12 +24 87115142 24Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 15%
2024Q3 Top 13% -60.3% -63.9%

Options Sentiment

Put holders
3
QoQ: +3
Call holders
3
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.40
EPS YoY
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -0.25 2024-06-30: EPS -0.18 2024-09-30: EPS -0.21 2024-12-31: EPS -0.59 2025-03-31: EPS -0.25 2025-06-30: EPS -0.29 2025-09-30: EPS -0.35 2025-12-31: EPS -0.51 2026-03-31: EPS -0.25 -0.65 -0.32 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)